dangers of bpc 157 FDA advisory committee votes to add popular peptide BPC-157 to drug compounding list bpc 157 clinical studies safety

This causes nausea, diarrhea, constipation, and abdominal discomfort regardless of whether the molecule entered through a needle or through sublingual absorption

Very rarely, some people experience: Mild itching or redness at injection site (if using injection) Slight weight gain (from better nutrient absorption) Compared to: NSAIDs (stomach ulcers, bleeding) Cortisone (weakens bones, immune suppression) Surgery (weeks of recovery) BPC-157 is remarkably safe References Chang, C

For subcutaneous or intramuscular chemotherapy, use CPT 96401 for non-hormonal agents or CPT 96402 for hormonal antineoplastic drugs

Still, one high-profile peptide enthusiast wants to make it easier to get peptides: Health Secretary Robert F